What are the differences in presentation of candidates for percutaneous mitral commissurotomy accross the world and do they influence the results of the procedure?

Archives of Cardiovascular Diseases

Volumn 101, Issue 10, 2008, Pages 611-617

  Marijon, Éloi ^a   Lung, Bernard ^a   Mocumbi, Ana Olga ^b   Kamblock, Joël ^c   Vo Thanh, Chien ^d   Gamra, Habib ^e   Esteves, Cesar ^f   Palacios, Igor F ^g   Vahanian, Alec ^a  

^a BICHAT HOSPITAL   (France)

^b Intituto do Coração   (Mozambique)

^c Cardiology Department   (French Polynesia)

^d CHO RAY HOSPITAL   (Viet Nam)

^e FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^f INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ballon mitral commissurotomy; Mitral stenosis; Rheumatic fever

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERVENTION STUDY; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE STENOSIS; OUTCOME ASSESSMENT; PATIENT SELECTION; PERCUTANEOUS MITRAL COMMISSUROTOMY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RHEUMATIC FEVER; SCHOOL CHILD;

EID: 57849146600     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2008.09.012     Document Type: Article

References (24)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro heart survey on valvular heart disease. Eur Heart J 2003;24:1231-43.
2. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, Geneva, 29 October-1 November 2001. World Health Organ Tech Rep Ser 2004;923:1-122.
3. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984;87:394-402.
4. Ben Farhat M, Ayari M, Maatouk F, et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation 1998;97:245-50.
5. Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994;331:961-7.
6. Vahanian A, Iung B, Pierard L, Dion R, Pepper J. Valvular diseases. In: Camm AJ, Lüscher TF, Serruys PW, editors. The ESC textbook of cardiovascular medicine. Oxford: Blackwell Publishing; 2006. p. 625-70.
7. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308.
8. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005;366:155-68.
9. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5:685-94.
10. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357:470-6.
11. Detter C, Fischlein T, Feldmeier C, Nollert G, Reichenspurner H, Reichart B. Mitral commissurotomy, a technique outdated? Long-term follow-up over a period of 35 years. Ann Thorac Surg 1999;68:2112-8.
12. Rihal CS, Schaff HV, Frye RL, Bailey KR, Hammes LN, Holmes Jr DR. Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: a useful surrogate for percutaneous balloon mitral valvuloplasty? J Am Coll Cardiol 1992;20:781-6.
13. Guedez Y, Kotby A, El-Demellawy M, et al. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 1999;99:2784-90.
14. Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis. JAMA 1993;270:1731-6.
15. Iung B, Cormier B, Ducimetiere P, et al. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation 1996;94:2124-30.
16. Iung B, Garbarz E, Michaud P, et al. Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation 1999;99:3272-8.
17. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation 2002;105:1465-71.
18. Complications and mortality of percutaneous balloon mitral commissurotomy. A report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. Circulation 1992;85:2014-24.
19. Post JR, Feldman T, Isner J, Herrmann HC. Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity. J Am Coll Cardiol 1995;25:1129-36.
20. Turgeman Y, Atar S, Rosenfeld T. The subvalvular apparatus in rheumatic mitral stenosis: methods of assessment and therapeutic implications. Chest 2003;124:1929-36.
21. Iung B, Nicoud-Houel A, Fondard O, et al. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur Heart J 2004;25:701-7.
22. Arora R, Kalra GS, Murty GS, et al. Percutaneous transatrial mitral commissurotomy: immediate and intermediate results. J Am Coll Cardiol 1994;23:1327-32.
23. Ben Farhat M, Betbout F, Gamra H, et al. Results of percutaneous double-balloon mitral commissurotomy in one medical center in Tunisia. Am J Cardiol 1995;76:1266-70.
24. Chen CR, Cheng TO. Percutaneous balloon mitral valvuloplasty by the Inoue technique: a multicenter study of 4832 patients in China. Am Heart J 1995;129:1197-203.